Is antinuclear antibody (ANA) positivity associated with hyperhidrosis?

No Established Association Between ANA Positivity and Hyperhidrosis

There is no recognized clinical correlation between antinuclear antibody (ANA) positivity and hyperhidrosis (excessive sweating). The available evidence does not support any pathophysiological link between these two findings.

Evidence Analysis

What ANA Testing Actually Detects

ANA testing is designed to identify autoantibodies associated with systemic autoimmune diseases, particularly:

• Systemic lupus erythematosus (SLE) - sensitivity >95% 1
• Systemic sclerosis (SSc)
• Sjögren's syndrome
• Mixed connective tissue disease
• Inflammatory myopathies

The international guidelines emphasize that ANA positivity is pivotal for diagnosing autoimmune diseases but can occur in up to 25% of healthy individuals without any clinical significance 1.

What the Research Shows

A comprehensive phenome-wide association study examining 70,043 individuals with positive and negative ANA tests found no association between ANA positivity and hyperhidrosis 2. This large-scale analysis specifically looked for clinical diagnoses associated with ANA positivity in both patients with and without autoimmune disease. Hyperhidrosis was not among the 88-136 clinical conditions identified as associated with ANA positivity.

The conditions that were associated with ANA positivity included:

• Autoimmune diseases (lupus, OR ≥5.4)
• Raynaud's syndrome (OR ≥2.1)
• Alveolar/perialveolar pneumopathies (OR ≥1.4)

Clinical Implications

If you encounter a patient with both ANA positivity and hyperhidrosis, these are coincidental findings requiring separate evaluation:

1. Evaluate the ANA positivity according to established guidelines:

   • Determine the titer and pattern 1
   • Consider clinical context for autoimmune disease
   • Order reflex testing for specific antibodies (anti-dsDNA, anti-ENA) if clinically indicated 1
   • Remember that ANA positivity alone does not establish autoimmune disease diagnosis

2. Evaluate the hyperhidrosis as a distinct entity:

   • Determine if primary (idiopathic, 2-5% prevalence) or secondary 3
   • For secondary hyperhidrosis, investigate other causes: medications, hyperthyroidism, infections, malignancy, neurological disorders
   • The hyperhidrosis workup should not be influenced by ANA status

Important Caveats

• Do not order ANA testing to evaluate hyperhidrosis - there is no clinical rationale
• Do not attribute hyperhidrosis to ANA positivity - this represents a misinterpretation of laboratory findings
• If both findings coexist in the context of other symptoms (arthralgia, rash, sicca symptoms), consider whether an underlying autoimmune disease might be causing secondary hyperhidrosis through autonomic dysfunction, but this would be rare and require additional supporting clinical features

The evidence is clear: ANA positivity and hyperhidrosis are unrelated phenomena that require independent clinical assessment and management.